India issues new clinical trial rules to expedite new drug approvals
Life Sciences Research & Analysis India issues new clinical trial rules to expedite new drug approvals 17 April 2019 Sacha Baggili The Indian...
Obtain the data you need to make the most informed decisions by accessing our extensive portfolio of information, analytics, and expertise. Sign in to the product or service center of your choice.
Customer LoginsSacha Baggili is an analyst in the life sciences team. She has 19 years of experience covering developments in healthcare policy, healthcare financing, biopharmaceutical market access and business intelligence, specializing in emerging markets. Sacha holds responsibility for the life sciences division's coverage on the Middle East, Africa, Turkey, India and Pakistan, as well as for analysis of health sector developments through supranational and not-for-profit organizations. Before joining IHS Markit in 2018, Sacha worked as an independent analyst, providing research services on global healthcare topics and on political, macroeconomic, regulatory, and trade risks in the Middle East and North Africa region; this included 12 years of continuous work with the Economist Intelligence Unit and its Bazian healthcare consultancy arm. She previously held positions as a Middle East country risk analyst at the World Markets Research Centre and as a senior healthcare analyst at Global Insight (both IHS Markit legacy companies). Sacha has also worked as a journalist in Jordan and Lebanon. She holds a BA in history and politics from the University of Exeter and a master's degree in international social policy from the University of Nottingham, focusing on global healthcare governance, policy analysis, and the socio-economic dynamics of the Middle East and Africa. She is a dual British-Jordanian national and speaks Arabic.
Eoin Ryan
Senior Analyst
Sophie Cairns
Senior Research Analyst, Life Sciences, IHS Markit
Anne Charlotte Ackermann, M.A
Principal Analyst, Life Sciences, IHS Markit